🇺🇸 FDA
Patent

US 11786635

Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration

granted A61KA61K35/34

Quick answer

US patent 11786635 (Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration) held by The Regents of the University of California expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K35/34